News for Healthier Living

First-in-Class Therapy Targets "Undruggable" Protein in Hard-to-Treat Blood Cancers

A first-in-class therapy to target MYC, one of the most sought-after and difficult targets in cancer biology, showed promise in hard-to-treat blood cancers, according to a new preclinical study from The University of Texas MD Anderson Cancer Center published in Blood.

August 21, 2026


September 1 2026

August 31 2026

August 30 2026

August 29 2026

August 28 2026

August 27 2026

August 26 2026

August 25 2026

August 24 2026

August 21 2026

August 20 2026

August 19 2026

August 18 2026